157
Participants
Start Date
October 1, 2013
Primary Completion Date
March 30, 2017
Study Completion Date
March 30, 2017
Buparlisib
Buparlisib comes in gelatin capsules and is taken orally at a dose of 100 mg/day.
Buparlisib matching Placebo
Buparlisib matching placebo comes in gelatin capsules and is taken orally at a dose of 100 mg/day.
Paclitaxel
Paclitaxel is an intravenous infusion that is given once every week in 80 mg/m\^2.
Novartis Investigative Site, Taichung
Novartis Investigative Site, Budapest
Novartis Investigative Site, Geneva
Novartis Investigative Site, St Leonards
Novartis Investigative Site, Basel
Novartis Investigative Site, Nyíregyháza
The Mount Sinai Hospital Dept of Oncology, New York
Novartis Investigative Site, Torino
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Berlin
UPMC Cancer Centers BKM120H2201, Pittsburgh
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Madrid
Novartis Investigative Site, Venezia
Novartis Investigative Site, Hanover
University Hospitals Case Medical Center Univ. Hospitals of Cleveland, Cleveland
Novartis Investigative Site, Saint-Herblain
Novartis Investigative Site, Essen
Novartis Investigative Site, Florence
Washington U School of Medicine Center for Clinical Studies SC - BKM120H2201, St Louis
Novartis Investigative Site, Tainan City
Highlands Oncology Group, Fayetteville
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Salerno
Novartis Investigative Site, Songkhla
Novartis Investigative Site, Palermo
Novartis Investigative Site, Dehli
Novartis Investigative Site, Leningrad Region
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Jaipur
Novartis Investigative Site, Kolkata
Dana Farber Cancer Institute IRB, Boston
University of N.C. at Chapel Hill Lineberger Comp. Cancer Ctr., Chapel Hill
Novartis Investigative Site, Hamilton
Novartis Investigative Site, Montreal
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Nashik
Novartis Investigative Site, Kerala
Novartis Investigative Site, Mumbai
Novartis Investigative Site, Dublin
Novartis Investigative Site, Nizhny Novgorod
Novartis Investigative Site, Roma
Novartis Investigative Site, Kashiwa
Novartis Investigative Site, Koto-ku
Novartis Investigative Site, Minato-ku
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Glasgow
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Manchester
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY